An analyst price target for DGX is US$151, 45% below the fair value estimate. A Discounted Cash Flow model is used to evaluate Quest Diagnostics as an investment opportunity, projecting future cash flows and discounting them.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing